GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Torrent Pharmaceuticals Ltd

Torrent Pharmaceuticals: Ameera Shah Ceases Independent Director Role on Aug 1, 2026

MANAGEMENT ● No Immediate Change LOW RISK
📅 Filed on BSE: 01 Aug 2026, 09:31 PM IST  ·  BSE ID: cb2b0bbe-8fa0-48d4-ab7a-68bb1c32e7b6
View Original BSE Filing (PDF)
💡
In Simple Terms
Torrent Pharmaceuticals announced an independent director, Ameera Shah, has finished her term and is no longer on the board.
🤖 AI Summary
  • Ameera Shah completed her Independent Director term on August 1, 2026.
  • She ceases to be a Director of Torrent Pharmaceuticals Limited.
  • The cessation is effective from August 1, 2026.
  • This follows other recent management changes reported July 30, 2026.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Cessation Date
01-Aug-26
🏢 How This Affects the Company
⚙️
Operational Impact
The company experiences a change in its board composition with the departure of an independent director.
⚠️
Risk Impact
The departure of a director can introduce a minor change in board oversight dynamics.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders regarding this director's cessation.
👤
Who Is Affected
All shareholders are informed of board composition changes; this event impacts governance transparency.
🔍
Management Signal
The company is adhering to its governance framework by noting the completion of a director's term.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Board meeting outcomes for new director appointments.
Future announcements on governance and board structure.
Torrent Pharma's next quarterly financial results release.
LOW RISK Cessation due to term completion is a standard governance event without inherent risk.
💡 Investor Takeaway
Ameera Shah has ceased her term as an Independent Director at Torrent Pharmaceuticals on August 1, 2026. This follows a reported restructuring impacting other senior management personnel.
❓ Frequently Asked Questions
Who ceased to be a Director at Torrent Pharmaceuticals and when?
Ameera Shah ceased to be an Independent Director at Torrent Pharmaceuticals on August 1, 2026, upon completion of her term.
What is the reason for Ameera Shah's cessation as Director at Torrent Pharmaceuticals?
Ameera Shah's cessation is due to the completion of her term as an Independent Director at Torrent Pharmaceuticals.
Is this change related to any recent management restructuring at Torrent Pharmaceuticals?
This cessation is in continuation of an earlier intimation dated July 30, 2026, which reported other senior management personnel departures.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.